Skip to main content

Diabetic Medicine 2013; 30(12): 1510-1511

The Association of British Clinical Diabetologists nationwide exenatide and liraglutide audits suggest a low incidence of acute pancreatitis. Response to Robson. Incretins and pancreatitis—what happens next? A personal viewpoint

R. E. J. Ryder1, P. Sen Gupta1,2, K. Y. Thong1 on behalf of the ABCD nationwide exenatide* and liraglutide audit contributors

1Department of Diabetes and Endocrinology, City Hospital, Birmingham, UK

2Diabetes Research Group, King’s College, London, UK

Epub 30 June 2013

Incidence of acute pancreatitis in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit

REJ Ryder1 and KY Thong2 on behalf of the ABCD nationwide exenatide audit contributors3

1Clinical Lead, ABCD Nationwide Audits; Consultant Physician (Diabetes), City Hospital, Birmingham, UK.

2Formerly Research Fellow, ABCD Nationwide Audits; Consultant Physician and Endocrinologist, Rockingham General Hospital, Perth, Western Australia.

In Hot topics in diabetes, 5th edition, Vora J, ed. Synergy, London, 2012: 49-61

Findings from the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits

REJ Ryder1 and KY Thong1, on behalf of the ABCD nationwide exenatide and nationwide liraglutide audit contributors

1City Hospital, Birmingham, UK

List of ABCD nationwide exenatide audit contributors